ALVAL — Valbiotis SA Share Price
0.000.00%
Last trade - 00:00- €66.96m
- €48.82m
- €4.73m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.42 | ||
| Price to Tang. Book | 3.62 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 14.15 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -29.27% | ||
| Return on Equity | -44.71% | ||
| Operating Margin | -151.7% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 0.09 | 3.09 | 0.3 | 0.79 | 4.73 | 8.33 | 27.07 | 126.73% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Valbiotis SA is a France-based company engaged in the biotechnology industry. The Company specializes in developing nutrition solutions designed to prevent cardiometabolic diseases and provide nutritional support for patients. It seeks to develop solutions designed to prevent type 2 diabetes, NASH, (non-alcoholic steatohepatitis) and obesity and to offer nutritional support. The Company prevents disease by developing products that reduce the risk factors of irreversible chronic diseases. It provides patient support through new-generation medical nutrition solutions containing patented substances with clinically proven effects. Its products are plant-based and undergo strict scientific and clinical tests in collaboration with academic research centers.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- February 11th, 2014
- Public Since
- June 7th, 2017
- No. of Employees
- 52
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 15,773,258
- Address
- 12F rue Paul Vatine, PERIGNY, 17180
- Web
- https://www.valbiotis.com/
- Phone
- +33 546286258
- Auditors
- Deloitte & Associes
Upcoming Events for ALVAL
Half Year 2024 Valbiotis SA Earnings Release
Similar to ALVAL
Abionyx Pharma SA
Euronext - Paris
Abivax SA
Euronext - Paris
Acticor Biotech SA
Euronext - Paris
Adocia SA
Euronext - Paris
Biophytis SA
Euronext - Paris
FAQ
What is the Valbiotis SA share price?
As of Today at 18:37 UTC, shares in Valbiotis SA are trading at €4.25. This share price information is delayed by 15 minutes.
How has the Valbiotis SA share price performed this year?
Shares in Valbiotis SA last closed at €4.25 and the price had moved by +15.67% over the past 365 days. In terms of relative price strength the Valbiotis SA share price has outperformed the FTSE Global All Cap Index by +3.5% over the past year.
What are the analyst and broker recommendations for Valbiotis SA?
The overall consensus recommendation for Valbiotis SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Valbiotis SA dividend yield?
Valbiotis SA does not currently pay a dividend.
Does Valbiotis SA pay a dividend?
Valbiotis SA does not currently pay a dividend.
When does Valbiotis SA next pay dividends?
Valbiotis SA does not currently pay a dividend.
How do I buy Valbiotis SA shares?
To buy shares in Valbiotis SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Valbiotis SA?
As of the previous close price of €4.25, shares in Valbiotis SA had a market capitalisation of €66.96m.
Where are Valbiotis SA shares listed?
Here are the trading details for Valbiotis SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALVAL
What kind of share is Valbiotis SA?
Based on an overall assessment of its quality, value and momentum Valbiotis SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Valbiotis SA share price forecast for 2024?
The analyst consensus target price for shares in Valbiotis SA is €9.90. That is 133.22% above the last closing price of €4.25.
Analysts covering Valbiotis SA currently have a consensus Earnings Per Share (EPS) forecast of -€0.77 for the next financial year.
What is the trend in the Valbiotis SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Valbiotis SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -35.12%.
As of the last closing price of €4.25, shares in Valbiotis SA were trading -9.79% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Valbiotis SA PE Ratio?
The Valbiotis SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €4.25.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Valbiotis SA?
We do not have data on Valbiotis SA's directors